Share Price and Basic Stock Data
Last Updated: January 2, 2026, 7:17 pm
| PEG Ratio | -4.30 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Fairchem Organics Ltd operates in the organic chemicals segment, where it reported a market capitalization of ₹999 Cr and a share price of ₹767. The company’s revenue trends have shown fluctuations over the past few quarters. Sales stood at ₹168.54 Cr in September 2022, declining to ₹102.48 Cr in December 2022, before recovering to ₹151.90 Cr in March 2023. However, sales have since stabilized around the ₹150 Cr mark, with ₹152.21 Cr reported in September 2023 and ₹148.11 Cr in December 2023. The trailing twelve months (TTM) revenue is recorded at ₹477 Cr, indicating a downward trend from ₹648 Cr in March 2023 to ₹538 Cr in March 2025. This decline in revenue reflects the ongoing challenges within the organic chemicals industry, which may be attributed to market dynamics and competition.
Profitability and Efficiency Metrics
Profitability metrics for Fairchem Organics have exhibited significant variability. The company reported a net profit of ₹6 Cr, translating to an earnings per share (EPS) of ₹16.88 for the fiscal year ending March 2025, down from ₹44 Cr and ₹33.41 EPS in March 2023. Operating profit margin (OPM) stood at 3.76% as of September 2025, showing a declining trend from 11% in March 2023. The interest coverage ratio (ICR) is robust at 12.03x, indicating that the company can comfortably meet its interest obligations. However, the cash conversion cycle has extended to 137 days, which is considerably longer than typical industry standards, suggesting inefficiencies in working capital management. Overall, while Fairchem’s profitability has faced headwinds, its ability to cover interest expenses remains strong.
Balance Sheet Strength and Financial Ratios
Fairchem Organics’ balance sheet reflects a cautious approach to leverage, with total borrowings reported at ₹54 Cr against reserves of ₹281 Cr as of September 2025. The company’s total assets stood at ₹388 Cr, with fixed assets at ₹199 Cr, indicating a stable asset base. The debt-to-equity ratio is relatively low at 0.20, suggesting a conservative capital structure. Moreover, the return on equity (ROE) is reported at 7.51%, while return on capital employed (ROCE) is at 10.2%, both of which are below the sector averages. The current ratio is healthy at 2.30, indicating sufficient liquidity to cover short-term obligations. However, the decrease in book value per share from ₹231.96 in March 2025 to ₹222.67 in March 2024 indicates a potential concern regarding shareholder value preservation.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Fairchem Organics illustrates a strong promoter presence, with promoters holding 61.20% of the company as of March 2025. This stable ownership structure can foster investor confidence, particularly among institutional investors, who hold a combined 11.95% (FIIs at 6.18% and DIIs at 5.77%). The total number of shareholders has slightly decreased from 32,869 in December 2022 to 28,990 by September 2025, indicating a potential decline in retail interest. The public holding has also reduced to 26.86% from 29.48% in December 2022. This shift might reflect investor sentiment amid the company’s declining revenue and profitability metrics. Overall, while promoter confidence remains high, the decreasing public shareholding may raise concerns about broader market sentiment towards the stock.
Outlook, Risks, and Final Insight
Looking ahead, Fairchem Organics faces a mixed outlook influenced by both opportunities and risks. The company’s ability to improve operational efficiencies and enhance profitability will be crucial in countering the declining revenue trend. However, risks such as prolonged market volatility in the organic chemicals sector and increased competition may hinder performance. The company’s extended cash conversion cycle poses a significant risk to liquidity and working capital efficiency. Should Fairchem manage to streamline operations and regain revenue momentum, it could stabilize its financial position. Conversely, failure to address these operational challenges may lead to further declines in profitability and investor confidence. The upcoming quarters will be critical as the company navigates these challenges and aims to restore growth.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gujchem Distillers India Ltd | 91.3 Cr. | 256 | 456/243 | 212 | 392 | 0.04 % | 0.21 % | 0.09 % | 1.00 |
| Elantas Beck India Ltd | 7,572 Cr. | 9,552 | 14,250/8,150 | 54.8 | 1,177 | 0.08 % | 23.0 % | 17.4 % | 10.0 |
| Crestchem Ltd | 34.2 Cr. | 114 | 329/109 | 16.9 | 26.9 | 0.88 % | 59.9 % | 44.1 % | 10.0 |
| Chemiesynth (Vapi) Ltd | 11.6 Cr. | 37.6 | 37.6/35.8 | 32.8 | 0.00 % | 3.10 % | 0.99 % | 10.0 | |
| ARCL Organics Ltd | 295 Cr. | 369 | 435/163 | 16.4 | 108 | 0.00 % | 20.4 % | 16.8 % | 10.0 |
| Industry Average | 4,682.75 Cr | 1,536.78 | 64.85 | 334.84 | 0.40% | 14.71% | 10.69% | 7.56 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 168.54 | 102.48 | 151.90 | 160.59 | 152.21 | 148.11 | 160.56 | 164.93 | 138.62 | 113.57 | 120.78 | 131.06 | 111.52 |
| Expenses | 159.22 | 98.81 | 132.66 | 148.96 | 135.38 | 128.36 | 141.79 | 143.16 | 129.86 | 105.74 | 116.36 | 125.83 | 107.33 |
| Operating Profit | 9.32 | 3.67 | 19.24 | 11.63 | 16.83 | 19.75 | 18.77 | 21.77 | 8.76 | 7.83 | 4.42 | 5.23 | 4.19 |
| OPM % | 5.53% | 3.58% | 12.67% | 7.24% | 11.06% | 13.33% | 11.69% | 13.20% | 6.32% | 6.89% | 3.66% | 3.99% | 3.76% |
| Other Income | 0.00 | 0.27 | 0.17 | 0.15 | 0.46 | 0.25 | 0.28 | 0.24 | 0.38 | 0.48 | 0.24 | 0.13 | 0.37 |
| Interest | 1.62 | 0.92 | 1.32 | 1.35 | 1.30 | 0.97 | 0.62 | 0.81 | 1.02 | 0.93 | 0.91 | 1.01 | 0.61 |
| Depreciation | 2.05 | 2.09 | 2.13 | 2.15 | 2.18 | 2.40 | 2.55 | 2.59 | 2.64 | 2.67 | 2.64 | 2.74 | 2.78 |
| Profit before tax | 5.65 | 0.93 | 15.96 | 8.28 | 13.81 | 16.63 | 15.88 | 18.61 | 5.48 | 4.71 | 1.11 | 1.61 | 1.17 |
| Tax % | 29.20% | 35.48% | 25.69% | 25.97% | 25.56% | 25.86% | 25.88% | 25.63% | 26.82% | 25.48% | 46.85% | 27.33% | 35.04% |
| Net Profit | 4.00 | 0.61 | 11.86 | 6.12 | 10.29 | 12.33 | 11.76 | 13.85 | 4.01 | 3.52 | 0.59 | 1.17 | 0.77 |
| EPS in Rs | 3.07 | 0.47 | 9.11 | 4.70 | 7.90 | 9.47 | 9.03 | 10.64 | 3.08 | 2.70 | 0.45 | 0.90 | 0.59 |
Last Updated: January 1, 2026, 7:37 pm
Below is a detailed analysis of the quarterly data for Fairchem Organics Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 111.52 Cr.. The value appears to be declining and may need further review. It has decreased from 131.06 Cr. (Jun 2025) to 111.52 Cr., marking a decrease of 19.54 Cr..
- For Expenses, as of Sep 2025, the value is 107.33 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 125.83 Cr. (Jun 2025) to 107.33 Cr., marking a decrease of 18.50 Cr..
- For Operating Profit, as of Sep 2025, the value is 4.19 Cr.. The value appears to be declining and may need further review. It has decreased from 5.23 Cr. (Jun 2025) to 4.19 Cr., marking a decrease of 1.04 Cr..
- For OPM %, as of Sep 2025, the value is 3.76%. The value appears to be declining and may need further review. It has decreased from 3.99% (Jun 2025) to 3.76%, marking a decrease of 0.23%.
- For Other Income, as of Sep 2025, the value is 0.37 Cr.. The value appears strong and on an upward trend. It has increased from 0.13 Cr. (Jun 2025) to 0.37 Cr., marking an increase of 0.24 Cr..
- For Interest, as of Sep 2025, the value is 0.61 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1.01 Cr. (Jun 2025) to 0.61 Cr., marking a decrease of 0.40 Cr..
- For Depreciation, as of Sep 2025, the value is 2.78 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2.74 Cr. (Jun 2025) to 2.78 Cr., marking an increase of 0.04 Cr..
- For Profit before tax, as of Sep 2025, the value is 1.17 Cr.. The value appears to be declining and may need further review. It has decreased from 1.61 Cr. (Jun 2025) to 1.17 Cr., marking a decrease of 0.44 Cr..
- For Tax %, as of Sep 2025, the value is 35.04%. The value appears to be increasing, which may not be favorable. It has increased from 27.33% (Jun 2025) to 35.04%, marking an increase of 7.71%.
- For Net Profit, as of Sep 2025, the value is 0.77 Cr.. The value appears to be declining and may need further review. It has decreased from 1.17 Cr. (Jun 2025) to 0.77 Cr., marking a decrease of 0.40 Cr..
- For EPS in Rs, as of Sep 2025, the value is 0.59. The value appears to be declining and may need further review. It has decreased from 0.90 (Jun 2025) to 0.59, marking a decrease of 0.31.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:23 am
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 306 | 397 | 643 | 648 | 621 | 538 | 477 |
| Expenses | 258 | 328 | 538 | 576 | 554 | 495 | 455 |
| Operating Profit | 49 | 69 | 105 | 72 | 67 | 43 | 22 |
| OPM % | 16% | 17% | 16% | 11% | 11% | 8% | 5% |
| Other Income | 6 | 0 | 0 | 1 | 1 | 1 | 1 |
| Interest | 7 | 7 | 7 | 6 | 4 | 4 | 3 |
| Depreciation | 6 | 7 | 7 | 8 | 9 | 11 | 11 |
| Profit before tax | 42 | 56 | 91 | 59 | 55 | 30 | 9 |
| Tax % | 18% | 24% | 26% | 26% | 26% | 27% | |
| Net Profit | 35 | 42 | 68 | 44 | 40 | 22 | 6 |
| EPS in Rs | 32.62 | 52.15 | 33.41 | 31.10 | 16.87 | 4.64 | |
| Dividend Payout % | 0% | 11% | 25% | 22% | 24% | 44% |
YoY Net Profit Growth
| Year | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 20.00% | 61.90% | -35.29% | -9.09% | -45.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | 41.90% | -97.20% | 26.20% | -35.91% |
Fairchem Organics Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 5 years from 2020-2021 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 12% |
| 3 Years: | -6% |
| TTM: | -19% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | -9% |
| 3 Years: | -31% |
| TTM: | -81% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -26% |
| 1 Year: | -38% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 19% |
| 3 Years: | 13% |
| Last Year: | 8% |
Last Updated: September 5, 2025, 3:50 am
Balance Sheet
Last Updated: December 4, 2025, 1:13 am
| Month | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|
| Equity Capital | 0.00 | 13 | 13 | 13 | 13 | 13 | 13 |
| Reserves | 127 | 156 | 219 | 246 | 277 | 289 | 281 |
| Borrowings | 67 | 57 | 62 | 50 | 7 | 63 | 54 |
| Other Liabilities | 25 | 33 | 30 | 33 | 37 | 37 | 40 |
| Total Liabilities | 219 | 259 | 324 | 342 | 334 | 402 | 388 |
| Fixed Assets | 126 | 126 | 141 | 156 | 191 | 201 | 199 |
| CWIP | 9 | 29 | 42 | 35 | 6 | 12 | 14 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 83 | 103 | 141 | 151 | 137 | 189 | 175 |
| Total Assets | 219 | 259 | 324 | 342 | 334 | 402 | 388 |
Below is a detailed analysis of the balance sheet data for Fairchem Organics Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 13.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 13.00 Cr..
- For Reserves, as of Sep 2025, the value is 281.00 Cr.. The value appears to be declining and may need further review. It has decreased from 289.00 Cr. (Mar 2025) to 281.00 Cr., marking a decrease of 8.00 Cr..
- For Borrowings, as of Sep 2025, the value is 54.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 63.00 Cr. (Mar 2025) to 54.00 Cr., marking a decrease of 9.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 40.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 37.00 Cr. (Mar 2025) to 40.00 Cr., marking an increase of 3.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 388.00 Cr.. The value appears to be improving (decreasing). It has decreased from 402.00 Cr. (Mar 2025) to 388.00 Cr., marking a decrease of 14.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 199.00 Cr.. The value appears to be declining and may need further review. It has decreased from 201.00 Cr. (Mar 2025) to 199.00 Cr., marking a decrease of 2.00 Cr..
- For CWIP, as of Sep 2025, the value is 14.00 Cr.. The value appears strong and on an upward trend. It has increased from 12.00 Cr. (Mar 2025) to 14.00 Cr., marking an increase of 2.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 175.00 Cr.. The value appears to be declining and may need further review. It has decreased from 189.00 Cr. (Mar 2025) to 175.00 Cr., marking a decrease of 14.00 Cr..
- For Total Assets, as of Sep 2025, the value is 388.00 Cr.. The value appears to be declining and may need further review. It has decreased from 402.00 Cr. (Mar 2025) to 388.00 Cr., marking a decrease of 14.00 Cr..
Notably, the Reserves (281.00 Cr.) exceed the Borrowings (54.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Free Cash Flow | -18.00 | 12.00 | 43.00 | 22.00 | 60.00 | -20.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Debtor Days | 45 | 43 | 35 | 35 | 33 | 58 |
| Inventory Days | 65 | 64 | 57 | 61 | 57 | 87 |
| Days Payable | 12 | 15 | 7 | 8 | 11 | 8 |
| Cash Conversion Cycle | 98 | 91 | 85 | 89 | 80 | 137 |
| Working Capital Days | 14 | 43 | 40 | 46 | 63 | 68 |
| ROCE % | 30% | 38% | 22% | 19% | 10% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 16.88 | 31.10 | 33.41 | 52.15 | 32.63 |
| Diluted EPS (Rs.) | 16.88 | 31.10 | 33.41 | 52.15 | 32.63 |
| Cash EPS (Rs.) | 24.97 | 38.23 | 39.67 | 57.63 | 37.68 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 231.96 | 222.67 | 199.11 | 178.29 | 129.59 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 231.96 | 222.67 | 199.11 | 178.29 | 129.59 |
| Dividend / Share (Rs.) | 7.50 | 7.50 | 7.50 | 13.00 | 3.50 |
| Revenue From Operations / Share (Rs.) | 413.10 | 477.29 | 497.69 | 493.96 | 304.56 |
| PBDIT / Share (Rs.) | 33.88 | 52.31 | 56.07 | 80.81 | 52.96 |
| PBIT / Share (Rs.) | 25.79 | 45.19 | 49.81 | 75.34 | 47.91 |
| PBT / Share (Rs.) | 22.98 | 41.93 | 45.00 | 70.07 | 42.67 |
| Net Profit / Share (Rs.) | 16.88 | 31.10 | 33.41 | 52.15 | 32.63 |
| PBDIT Margin (%) | 8.20 | 10.96 | 11.26 | 16.36 | 17.38 |
| PBIT Margin (%) | 6.24 | 9.46 | 10.00 | 15.25 | 15.73 |
| PBT Margin (%) | 5.56 | 8.78 | 9.04 | 14.18 | 14.01 |
| Net Profit Margin (%) | 4.08 | 6.51 | 6.71 | 10.55 | 10.71 |
| Return on Networth / Equity (%) | 7.27 | 13.96 | 16.77 | 29.25 | 25.17 |
| Return on Capital Employeed (%) | 10.38 | 19.08 | 23.52 | 38.21 | 30.01 |
| Return On Assets (%) | 5.46 | 12.11 | 12.70 | 20.95 | 16.42 |
| Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.00 | 0.04 | 0.15 |
| Total Debt / Equity (X) | 0.20 | 0.02 | 0.19 | 0.26 | 0.28 |
| Asset Turnover Ratio (%) | 1.46 | 1.84 | 1.94 | 2.21 | 1.66 |
| Current Ratio (X) | 2.30 | 5.10 | 2.22 | 2.04 | 1.93 |
| Quick Ratio (X) | 1.17 | 2.42 | 1.03 | 0.99 | 1.04 |
| Inventory Turnover Ratio (X) | 6.81 | 8.31 | 6.69 | 8.17 | 6.89 |
| Dividend Payout Ratio (NP) (%) | 44.44 | 24.11 | 38.91 | 6.71 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 30.04 | 19.61 | 32.77 | 6.07 | 0.00 |
| Earning Retention Ratio (%) | 55.56 | 75.89 | 61.09 | 93.29 | 0.00 |
| Cash Earning Retention Ratio (%) | 69.96 | 80.39 | 67.23 | 93.93 | 0.00 |
| Interest Coverage Ratio (X) | 12.03 | 16.07 | 11.66 | 15.35 | 10.11 |
| Interest Coverage Ratio (Post Tax) (X) | 6.99 | 10.55 | 7.95 | 10.91 | 7.23 |
| Enterprise Value (Cr.) | 1202.96 | 1552.81 | 1240.34 | 2021.19 | 1022.58 |
| EV / Net Operating Revenue (X) | 2.24 | 2.50 | 1.91 | 3.14 | 2.58 |
| EV / EBITDA (X) | 27.27 | 22.80 | 16.99 | 19.21 | 14.83 |
| MarketCap / Net Operating Revenue (X) | 2.12 | 2.49 | 1.84 | 3.05 | 2.46 |
| Retention Ratios (%) | 55.55 | 75.88 | 61.08 | 93.28 | 0.00 |
| Price / BV (X) | 3.78 | 5.33 | 4.59 | 8.44 | 5.78 |
| Price / Net Operating Revenue (X) | 2.12 | 2.49 | 1.84 | 3.05 | 2.46 |
| EarningsYield | 0.01 | 0.02 | 0.03 | 0.03 | 0.04 |
After reviewing the key financial ratios for Fairchem Organics Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 16.88. This value is within the healthy range. It has decreased from 31.10 (Mar 24) to 16.88, marking a decrease of 14.22.
- For Diluted EPS (Rs.), as of Mar 25, the value is 16.88. This value is within the healthy range. It has decreased from 31.10 (Mar 24) to 16.88, marking a decrease of 14.22.
- For Cash EPS (Rs.), as of Mar 25, the value is 24.97. This value is within the healthy range. It has decreased from 38.23 (Mar 24) to 24.97, marking a decrease of 13.26.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 231.96. It has increased from 222.67 (Mar 24) to 231.96, marking an increase of 9.29.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 231.96. It has increased from 222.67 (Mar 24) to 231.96, marking an increase of 9.29.
- For Dividend / Share (Rs.), as of Mar 25, the value is 7.50. This value exceeds the healthy maximum of 3. There is no change compared to the previous period (Mar 24) which recorded 7.50.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 413.10. It has decreased from 477.29 (Mar 24) to 413.10, marking a decrease of 64.19.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 33.88. This value is within the healthy range. It has decreased from 52.31 (Mar 24) to 33.88, marking a decrease of 18.43.
- For PBIT / Share (Rs.), as of Mar 25, the value is 25.79. This value is within the healthy range. It has decreased from 45.19 (Mar 24) to 25.79, marking a decrease of 19.40.
- For PBT / Share (Rs.), as of Mar 25, the value is 22.98. This value is within the healthy range. It has decreased from 41.93 (Mar 24) to 22.98, marking a decrease of 18.95.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 16.88. This value is within the healthy range. It has decreased from 31.10 (Mar 24) to 16.88, marking a decrease of 14.22.
- For PBDIT Margin (%), as of Mar 25, the value is 8.20. This value is below the healthy minimum of 10. It has decreased from 10.96 (Mar 24) to 8.20, marking a decrease of 2.76.
- For PBIT Margin (%), as of Mar 25, the value is 6.24. This value is below the healthy minimum of 10. It has decreased from 9.46 (Mar 24) to 6.24, marking a decrease of 3.22.
- For PBT Margin (%), as of Mar 25, the value is 5.56. This value is below the healthy minimum of 10. It has decreased from 8.78 (Mar 24) to 5.56, marking a decrease of 3.22.
- For Net Profit Margin (%), as of Mar 25, the value is 4.08. This value is below the healthy minimum of 5. It has decreased from 6.51 (Mar 24) to 4.08, marking a decrease of 2.43.
- For Return on Networth / Equity (%), as of Mar 25, the value is 7.27. This value is below the healthy minimum of 15. It has decreased from 13.96 (Mar 24) to 7.27, marking a decrease of 6.69.
- For Return on Capital Employeed (%), as of Mar 25, the value is 10.38. This value is within the healthy range. It has decreased from 19.08 (Mar 24) to 10.38, marking a decrease of 8.70.
- For Return On Assets (%), as of Mar 25, the value is 5.46. This value is within the healthy range. It has decreased from 12.11 (Mar 24) to 5.46, marking a decrease of 6.65.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.20. This value is within the healthy range. It has increased from 0.02 (Mar 24) to 0.20, marking an increase of 0.18.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.46. It has decreased from 1.84 (Mar 24) to 1.46, marking a decrease of 0.38.
- For Current Ratio (X), as of Mar 25, the value is 2.30. This value is within the healthy range. It has decreased from 5.10 (Mar 24) to 2.30, marking a decrease of 2.80.
- For Quick Ratio (X), as of Mar 25, the value is 1.17. This value is within the healthy range. It has decreased from 2.42 (Mar 24) to 1.17, marking a decrease of 1.25.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.81. This value is within the healthy range. It has decreased from 8.31 (Mar 24) to 6.81, marking a decrease of 1.50.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 44.44. This value is within the healthy range. It has increased from 24.11 (Mar 24) to 44.44, marking an increase of 20.33.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 30.04. This value is within the healthy range. It has increased from 19.61 (Mar 24) to 30.04, marking an increase of 10.43.
- For Earning Retention Ratio (%), as of Mar 25, the value is 55.56. This value is within the healthy range. It has decreased from 75.89 (Mar 24) to 55.56, marking a decrease of 20.33.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 69.96. This value is within the healthy range. It has decreased from 80.39 (Mar 24) to 69.96, marking a decrease of 10.43.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 12.03. This value is within the healthy range. It has decreased from 16.07 (Mar 24) to 12.03, marking a decrease of 4.04.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 6.99. This value is within the healthy range. It has decreased from 10.55 (Mar 24) to 6.99, marking a decrease of 3.56.
- For Enterprise Value (Cr.), as of Mar 25, the value is 1,202.96. It has decreased from 1,552.81 (Mar 24) to 1,202.96, marking a decrease of 349.85.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.24. This value is within the healthy range. It has decreased from 2.50 (Mar 24) to 2.24, marking a decrease of 0.26.
- For EV / EBITDA (X), as of Mar 25, the value is 27.27. This value exceeds the healthy maximum of 15. It has increased from 22.80 (Mar 24) to 27.27, marking an increase of 4.47.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.12. This value is within the healthy range. It has decreased from 2.49 (Mar 24) to 2.12, marking a decrease of 0.37.
- For Retention Ratios (%), as of Mar 25, the value is 55.55. This value is within the healthy range. It has decreased from 75.88 (Mar 24) to 55.55, marking a decrease of 20.33.
- For Price / BV (X), as of Mar 25, the value is 3.78. This value exceeds the healthy maximum of 3. It has decreased from 5.33 (Mar 24) to 3.78, marking a decrease of 1.55.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.12. This value is within the healthy range. It has decreased from 2.49 (Mar 24) to 2.12, marking a decrease of 0.37.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. It has decreased from 0.02 (Mar 24) to 0.01, marking a decrease of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Fairchem Organics Ltd:
- Net Profit Margin: 4.08%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 10.38% (Industry Average ROCE: 14.71%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 7.27% (Industry Average ROE: 10.69%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 6.99
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.17
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 165 (Industry average Stock P/E: 64.85)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.2
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 4.08%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Organic - Others | 253/P & 312, Village Chekhala, Ahmedabad District Gujarat 382115 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Nahoosh Jariwala | Chairman & Managing Director |
| Mr. Sudhin Choksey | Independent Director |
| Mr. Venkatraman Srinivasan | Independent Director |
| Mr. Darius Pandole | Independent Director |
| Ms. Sonal Ambani | Independent Director |
| Mr. Sumit Maheshwari | Nominee Director |
FAQ
What is the intrinsic value of Fairchem Organics Ltd?
Fairchem Organics Ltd's intrinsic value (as of 02 January 2026) is ₹2262.34 which is 194.96% higher the current market price of ₹767.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹999 Cr. market cap, FY2025-2026 high/low of ₹1,230/542, reserves of ₹281 Cr, and liabilities of ₹388 Cr.
What is the Market Cap of Fairchem Organics Ltd?
The Market Cap of Fairchem Organics Ltd is 999 Cr..
What is the current Stock Price of Fairchem Organics Ltd as on 02 January 2026?
The current stock price of Fairchem Organics Ltd as on 02 January 2026 is ₹767.
What is the High / Low of Fairchem Organics Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Fairchem Organics Ltd stocks is ₹1,230/542.
What is the Stock P/E of Fairchem Organics Ltd?
The Stock P/E of Fairchem Organics Ltd is 165.
What is the Book Value of Fairchem Organics Ltd?
The Book Value of Fairchem Organics Ltd is 226.
What is the Dividend Yield of Fairchem Organics Ltd?
The Dividend Yield of Fairchem Organics Ltd is 0.98 %.
What is the ROCE of Fairchem Organics Ltd?
The ROCE of Fairchem Organics Ltd is 10.2 %.
What is the ROE of Fairchem Organics Ltd?
The ROE of Fairchem Organics Ltd is 7.51 %.
What is the Face Value of Fairchem Organics Ltd?
The Face Value of Fairchem Organics Ltd is 10.0.